Altos Eye Physicians Joins the AcuFocus IC-8® Lens Clinical Study for Patients with Cataracts

LOS ALTOS, Calif.--(BUSINESS WIRE)-- Bryan Lee, M.D., J.D. at Altos Eye Physicians in Los Altos, Calif., is participating in the AcuFocus clinical study for the IC-8 intraocular lens (IOL) designed for patients with cataracts.

By the age of 65, an estimated 90% of people worldwide experience changes to the natural crystalline lens of the eye. The lens gradually becomes cloudy as a cataract develops, leading to blurry vision and eventually vision loss. The only treatment for a visually significant cataract is the surgical removal of the natural lens and its replacement with an artificial lens called an IOL. More than 25 million cataract procedures are performed worldwide each year. The majority of patients with cataracts are treated with a standard monofocal (single-focus) lens, which allows the patient to have good far vision; however, patients remain dependent on glasses for near and intermediate vision.

“Cataracts are the leading cause of vision loss for people over 40 but are fortunately treatable,” said Dr. Lee. “Our goal is to provide the most function possible postoperatively. Because of this, our team is dedicated to providing the newest treatment advancements from new surgical techniques to advances in intraocular lenses. We’re looking forward to serving as a clinical study site for potential cataract solutions such as the IC-8 lens. Over the coming months, we will be working with cataract patients to investigate how the IC-8 lens compares to a single focus lens.”

Dr. Lee will be one of a select group of clinical investigators across the United States for the IC-8 lens study. The IC-8 lens is a clear monofocal lens with a mini-ring placed in the center. The mini-ring has an opening, or pinhole, designed to increase the range of vision by extending the focus of light rays that enter the eye. The clinical study will determine if the IC-8 lens in one eye, when paired with a standard monofocal lens in the other eye, will provide near and intermediate vision in addition to far vision for cataract patients.

Altos Eye Physicians is now enrolling patients that meet the study eligibility criteria. Patients who comply with study commitments will be compensated. Some basic qualifications include the following:

• At least 22 years of age.
• Have cataracts in both eyes.
• Are available, willing, and able to participate in examinations and all follow-up study visits and appointments.

If you are interested in becoming a volunteer participant in the IC-8 lens clinical study, please contact Tera Yee at Altos Eye Physicians at (650) 948-9123 or at teraaltoseye@gmail.com.

ABOUT US

Altos Eye Physicians in Los Altos, Calif., has been providing high-quality care to patients in the Bay Area for over 50 years. Our highly trained physicians are board certified in the medical and surgical treatment of eye diseases. We are a comprehensive ophthalmology practice and specialize in routine eye care as well as complex medical and surgical eye diseases. Our state-of-the-art facilities and personnel have been carefully chosen to provide the best care for you. In addition to caring for your vision and the health of your eyes, we make a special effort to explain your condition to you in clear language and encourage you to ask questions. We value our relationship with you and look forward to helping you maintain good vision and healthy eyes.

762 Altos Oaks Dr. #1
Los Altos CA 94024
(650) 948-9123
www.altoseye.com
www.bryanlee.pro

ABOUT ACUFOCUS & THE IC-8 IOL

AcuFocus, Inc., is a privately held ophthalmic medical device company that develops and markets breakthrough technologies for the improvement of vision. The IC-8 lens received its CE mark in 2014 and is available in select markets across Europe and Asia. Founded in 2001, AcuFocus is based in Irvine, Calif. For additional information about the IC-8 intraocular lens, visit www.ic8lensclinicalstudy.com or https://www.facebook.com/ic8lensclinicalstudy.

Caution: Investigational Device. Limited by Federal (or United States) law to investigational use.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190514005218/en/